Safety and Efficacy of Ranibizumab in Diabetic Macular Edema
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study was designed to confirm the efficacy and safety of laser photocoagulation as
adjunctive therapy to ranibizumab 0.5 mg versus laser monotherapy in patients with visual
impairment due to Diabetic Macular Edema. A subgroup of patients with Proliferative Diabetic
Retinopathy were included to evaluate the efficacy and safety of laser photocoagulation as
adjunctive therapy to ranibizumab 0.5 mg versus laser monotherapy in this population.